Register entry
- Registered sites
- 4
- Active NDC listings
- 47
- Labeller names
- 3
- Live patents
- 0
- Countries
- 4
- Base
- United States
Authorisation
Registered operations
Analytical testing4Active ingredient (API) manufacture4Finished drug manufacture3
Sites
Registered establishments
4| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| HOVIONE LIMITEDRegistrant: HOVIONE FARMACIENCIA, S.A. | Loughbeg, RINGASKIDDY, CORK P43 DY23, Ireland (IRL) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3008058822985003840 |
| HOVIONE PHARMASCIENCE LIMITEDRegistrant: HOVIONE FARMACIENCIA, S.A. | 154 Estrada Coronel Nicolau de Mesquita, Taipa, -, Macau (MAC) | Analytical testing, Active ingredient (API) manufacture | 3002807210854974342 |
| HOVIONE FARMACIENCIA, S.A. | Quinta Sao Pedro, Loures, 2674-506, Portugal (PRT) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3002807208449818434 |
| HOVIONE LLCRegistrant: HOVIONE FARMACIENCIA, S.A. | 40 Lake Dr, East Windsor, New Jersey (NJ) 08520-5321, United States (USA) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3006106736038153735 |
Catalogue
Drug listings by form and route
4747 active NDC listings: 30 drug for further processing, 17 bulk ingredient. By marketing category: DRUG FOR FURTHER PROCESSING 30, BULK INGREDIENT 17.
| Dosage form | NDCs |
|---|---|
| powder | 45 |
| capsule | 1 |
| tablet, coated | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| hovione farmaciencia sa | 21 |
| hovione farmaciencia sa | 21 |
| hovione farmaciencia s.a. | 5 |
Catalogue
Marketed products
47| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | 26% HM30181 based solid dispersion | powder | 50909-1904DRUG FOR FURTHER PROCESSING |
| - | ALXN2040/HPMCAS Solid Dispersion | powder | 50909-1907DRUG FOR FURTHER PROCESSING |
| - | Apalutamide solid dispersion intermediate | powder | 50909-1912DRUG FOR FURTHER PROCESSING |
| - | Belzutifan Spray Dried Intermediate | powder | 50909-1917DRUG FOR FURTHER PROCESSING |
| - | Betamethasone Acetate | powder | 50909-5103BULK INGREDIENT |
| - | Betamethasone sodium phosphate | powder | 50909-5102BULK INGREDIENT |
| - | DHE Spray Dried Dispersion | powder | 50909-1926DRUG FOR FURTHER PROCESSING |
| - | Deutivacaftor spray dried dispersion | powder | 50909-1908DRUG FOR FURTHER PROCESSING |
| - | Doravirine Spray Dried | powder | 50909-1918DRUG FOR FURTHER PROCESSING |
| - | Doxycycline | powder | 50909-8106BULK INGREDIENT |
| - | Doxycycline Hyclate | powder | 50909-8105BULK INGREDIENT |
| - | ENSIFENTRINE | powder | 50909-1705BULK INGREDIENT |
| - | Elbasvir SD | powder | 50909-1919DRUG FOR FURTHER PROCESSING |
| - | Fluticasone Propionate | powder | 50909-5175BULK INGREDIENT |
| - | Fluticasone furoate | powder | 50909-5171BULK INGREDIENT |
| - | Grazoprevir SD | powder | 50909-1916DRUG FOR FURTHER PROCESSING |
| - | HYDROCORTISONE ACEPONATE | powder | 50909-5263BULK INGREDIENT |
| - | Halobetasol Propionate | powder | 50909-5157BULK INGREDIENT |
| - | ISAVUCONAZONIUM SULFATE | powder | 50909-1703BULK INGREDIENT |
| - | Ivacaftor spray dried dispersion | powder | 50909-1902DRUG FOR FURTHER PROCESSING |
| - | Ivosidenib solid dispersion intermediate | powder | 50909-1909DRUG FOR FURTHER PROCESSING |
| - | Ledipasvir SDD 50% w/w | powder | 50909-1920DRUG FOR FURTHER PROCESSING |
| - | MOMETASONE FUROATE MONOHYDRATE | powder | 50909-5152BULK INGREDIENT |
| - | Minocycline Hydrochloride | powder | 50909-9101BULK INGREDIENT |
| - | Minocycline Hydrochloride | powder | 50909-9201BULK INGREDIENT |
| - | Mometasone Furoate | powder | 50909-5151BULK INGREDIENT |
| - | Orforglipron SDD | powder | 50909-1924DRUG FOR FURTHER PROCESSING |
| - | Orforglipron SDD | powder | 50909-1925DRUG FOR FURTHER PROCESSING |
| - | Paltusotine.HCl SDD | powder | 50909-1913DRUG FOR FURTHER PROCESSING |
| - | Pirtobrutinib SDD | powder | 50909-1923DRUG FOR FURTHER PROCESSING |
| - | Pralsetinib SDD intermediate | powder | 50909-1905DRUG FOR FURTHER PROCESSING |
| - | QUIZARTINIB DIHYDROCHLORIDE SDD | powder | 50909-1915DRUG FOR FURTHER PROCESSING |
| - | Salmeterol Xinafoate | powder | 50909-4102BULK INGREDIENT |
| - | Sarolaner SDD | powder | 50909-1901DRUG FOR FURTHER PROCESSING |
| - | Solid Dispersion of BMS-986165-01 | powder | 50909-1906DRUG FOR FURTHER PROCESSING |
| - | Sonrotoclax (BGB-11417) SDD | powder | 50909-1928DRUG FOR FURTHER PROCESSING |
| - | Suzetrigine spay dried dispersion | powder | 50909-1910DRUG FOR FURTHER PROCESSING |
| - | Tenapanor hydrochloride | powder | 50909-1706BULK INGREDIENT |
| - | Tezacaftor spray dried dispersion | powder | 50909-1903DRUG FOR FURTHER PROCESSING |
| - | Tobramycin 28mg Inhalation Powder Hard Capsule | capsule | 50909-2001DRUG FOR FURTHER PROCESSING |
| - | Tucatinib solid dispersion intermediate | powder | 50909-1911DRUG FOR FURTHER PROCESSING |
| - | Velpatasvir SDD 50% w/w | powder | 50909-1921DRUG FOR FURTHER PROCESSING |
| - | Vepdegestrant Spray Dried Dispersion | powder | 50909-1927DRUG FOR FURTHER PROCESSING |
| - | Viseltinib | powder | 50909-1707BULK INGREDIENT |
| - | Voxilaprevir SDD | powder | 50909-1922DRUG FOR FURTHER PROCESSING |
| - | Zongertinib Film-Coated Tablets, 60 mg | tablet, coated | 50909-2002DRUG FOR FURTHER PROCESSING |
| - | Zongertinib SDD intermediate | powder | 50909-1914DRUG FOR FURTHER PROCESSING |
Neighbours
Registered in the same town
6- Pfizer IncRINGASKIDDY, IRL
- Aurolife Pharma LLCEast Windsor, NJ
- Apnar Pharma Private LimitedEAST WINDSOR, NJ
- Esjay Pharma Private LimitedEast Windsor, NJ
- Novitium Pharma LLCEast Windsor, NJ
- RK Pharma IncEast Windsor, NJ
Compare
Comparable companies in United States
- Hikma Pharmaceuticals USA Inc.4 sites · 763 NDC
- Church & Dwight Co., Inc.4 sites · 157 NDC
- Sterling Pharmaceutical Services, LLC4 sites · 104 NDC
- Bausch & Lomb Ireland Limited4 sites · 92 NDC
- Grifols Therapeutics LLC4 sites · 53 NDC
- Gilead Sciences, Inc.4 sites · 51 NDC
- Nice-Pak Products, LLC4 sites · 48 NDC
- Pacific Medical Industries Ltd4 sites · 41 NDC
- United Therapeutics Corporation4 sites · 40 NDC
- Avantor Performance Materials, LLC4 sites · 33 NDC
Enquiry
Common questions
- Is HOVIONE FARMACIENCIA, S.A. FDA approved?
- HOVIONE FARMACIENCIA, S.A. holds 4 FDA-registered establishments across 4 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are HOVIONE FARMACIENCIA, S.A.'s drugs manufactured?
- At registered sites in Ireland, Macau, Portugal, the United States. The FDA register lists RINGASKIDDY; Taipa; Loures; East Windsor, NJ. Registered operations: analytical testing, active ingredient (API) manufacture, finished drug manufacture.
- What drugs does HOVIONE FARMACIENCIA, S.A. make?
- 47 products are listed under HOVIONE FARMACIENCIA, S.A. in the openFDA NDC Directory, most often as powder; capsule; tablet, coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.